Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?

Objective: Our objective was to evaluate the association of benign prostatic hyperplasia (BPH) with each component of metabolic syndrome (MS), and determine which component plays the major risk for developing BPH. Materials and Methods: This cross-sectional observational study was performed on 203 male patients aged over 50, who came to the internal medicine outpatient clinics just for a check-up with/without any known disease. Forty-three of them were healthy control patients and the rest had only 1 criterion of MS. They were searched for the presence of BPH. Results: BPH prevalence ranged between 45.5-65.6% in the subgroups, there was no statistically significant difference in the presence of BPH between these groups. There was a slight positive correlation between glucose level and prostate volume. Triglyceride levels were positively correlated with [Q.sub.max] and negatively correlated with the grade of hypertrophy. There was also a slight positive correlation between systolic blood pressure and prostate volumes, grade of hypertrophy, and IPSS scores. Conclusion: BPH prevalence was not different between MS components. We concluded that none of the MS components increase the occurrence of BPH by itself but when those metabolic disorders come together and form a syndrome, the prevalence of BPH increases. Keywords: Metabolic syndrome, benign prostatic hyperplasia, hyperglycemia, hypertension, dyslipidemia, obesity.